MiR-130a and MiR-374a function as novel regulators of cisplatin resistance in human ovarian cancer A2780 cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Li, Ningwei ^a   Yang, Lingyun ^a   Wang, Hongjing ^a   Yi, Tao ^a   Jia, Xibiao ^a   Chen, Cen ^a   Xu, Pan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 130A; MICRORNA 374A; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; MESSENGER RNA; MIRN130 MICRORNA, HUMAN; MIRN374 MICRORNA 374, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER STAGING; CELL VIABILITY; CONTROLLED STUDY; DEREGULATION; DOWN REGULATION; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARIAN NEOPLASMS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TUMOR CELL LINE;

CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; P-GLYCOPROTEINS; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSFECTION;

EID: 84934981798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128886     Document Type: Article

References (32)

1. Naishadham D, Jemal A. (2013) Cancer statistics, online.
2. th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95: S161-S192. PMID: 17161157
3. Foster T, Brown TM, Chang J, Menssen HD, Blieden MB, Herzog TJ. (2009) A review of the current evidence for maintenance therapy in ovarian cancer. Gynecol Oncol 115: 290-301. doi: 10.1016/j.ygyno.2009.07.026 PMID: 19717182
4. Gottesman MM, Ling V. (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett.; 580(4):998-1009. PMID: 16405967
5. Materon EM, Jimmy Huang PJ, Wong A, Pupim Ferreira AA, Sotomayor Mdel P, Liu J. (2014) Glutathione-s-transferase modified electrodes for detecting anticancer drugs. Biosens Bioelectron. 58C:232-236. doi: 10.1016/j.bios.2014.10.046 PMID: 25461163
6. Fraser M, Bai T, Tsang BK, Quinn MA, Benedet JL, Creasman WT, et al. (2008) Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Int J Cancer. 122(3): 534-546. PMID: 17918180
7. Kirschner K, Melton DW. (2010) Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Anticancer Res. 30(9):3223-3232. PMID: 20944091
8. Bartel DP. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function.Cell, 116: 281-97. PMID: 14744438
9. Anglicheau D, Muthukumar T, Suthanthiran M. (2010) MicroRNAs: small RNAs with big effects. Transplantation. 90:105-112. doi: 10.1097/TP.0b013e3181e913c2 PMID: 20574417
10. Chiang CH, Hou MF, Hung WC. (2013) Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta. 1830(4):3067-76. doi: 10.1016/j.bbagen.2013.01.009 PMID: 23333633
11. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, et al.(2009) miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 7(8):1234-43. doi: 10.1158/1541-7786.MCR-08-0507 PMID: 19671678
12. Moitra K, Im K, Limpert K, Borsa A, Sawitzke J, Robey R, et al. (2012) Differential gene and microRNA expression between etoposide resistant and etoposide sensitive MCF7 breast cancer cell lines. PLOS ONE, 7(9):e45268. doi: 10.1371/journal.pone.0045268 PMID: 23028896
13. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 299(4):425-36. doi: 10.1001/jama.299.4.425 PMID: 18230780
14. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, et al. (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA. 107(49):21098-103. doi: 10.1073/pnas.1015541107 PMID: 21078976
15. Yang LY, Wang HJ,Li NW, Jia X, Wang X, Luo J. (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep, 28(2): 592-600. doi: 10.3892/or.2012.1823 PMID: 22614869
16. Pan YZ, Morris ME, Yu AM. (2009) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol. 75(6):1374-9 doi: 10.1124/mol.108.054163 PMID: 19270061
17. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, et al. (2008) Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC, et al.3 cells. Biochem Biophys Res Commun. 377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086 PMID: 18834855
18. Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, et al. (2010) MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol. 119(1):125-30 doi: 10.1016/j.ygyno.2010.06.004 PMID: 20624637
19. Takiuchi D, Eguchi H, Nagano H, Iwagami Y, Tomimaru Y, Wada H, et al. (2013) Involvement of micro-RNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology. 13(5):517-23. doi: 10.1016/j.pan.2013.06.007 PMID: 24075517
20. Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, et al. (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun, 425(2):468-472. doi: 10.1016/j.bbrc.2012.07.127 PMID: 22846564
21. Cui XY, Guo YJ, Yao HR. (2008) Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR. Nan Fang Yi Ke Da Xue Xue Bao, 28(10):1813-1815. PMID: 18971180
22. Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, et al. (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 7(10):e48086., doi: 10.1371/journal.pone.0048086 PMID: 23133552
23. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ. (2010) Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis., 11(1):50-54. doi: 10.1111/j.1751-2980.2009.00413.x PMID: 20132431
24. Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, et al. (2013) MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest. 123(2):566-579. doi: 10.1172/JCI65871 PMID: 23321667
25. Leonard GD, Fojo T, Bates SE. (2003) The role of ABC transporters in clinical practice. Oncologist, 8(5):411-424. PMID: 14530494
26. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther. 7(7): 2152-2159. doi: 10.1158/1535-7163.MCT-08-0021 PMID: 18645025
27. Carracedo A, Alimonti A, Pandolfi PP. (2011) PTEN level in tumor suppression: how much is too little? Cancer Res, 71(3):629-633. doi: 10.1158/0008-5472.CAN-10-2488 PMID: 21266353
28. Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen H, et al.(2012) KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One. 7(5):e36653. doi: 10.1371/journal.pone.0036653 PMID: 22586484
29. Buscaglia LE, Li Y. (2011) Apoptosis and the target genes of microRNA-21. Chin J Cancer, 30(6):371-380. PMID: 21627859
30. hun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, et al. (2010) MicroRNA-221 and micro- RNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer,. 10:367. doi: 10.1186/1471-2407-10-367 PMID: 20618998
31. Xiong X, Chorzalska A, Dubielecka P M, White JR, Vedvyas Y, Hedvat CV, et al. (2012) Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice. Oncogenesis. 1(9): e26. doi: 10.1038/oncsis.2012.28
32. Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, et al. (2014) MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. 33(3):378-86. doi: 10.1038/onc.2012.575 PMID: 23318422